Tumor-infiltrating lymphocytes (TILs) are immune cells that naturally recognize and penetrate tumors to kill cancer cells, ...

Report Ocean is a leading provider of in-depth market research reports, analyzing over 150 countries’ markets. With a focus on accuracy, their team of expert researchers and pro ...

Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the "Company"), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second ...

"This enhanced understanding of the regulation of spermatogenesis provides the foundation for further studies including ...

The growing prevalence of chronic diseases is a major factor driving revenue growth in the natural killer (NK) cell ...

By 2030, the cell and gene therapy market is projected to be worth £76.03bn, and logistics is essential in realising the potential.

With over a decade of experience in stem cell therapy, Swiss Medica provides individualized treatment programs for complex neurological conditions.

Vor Bio is the latest cell therapy company to reach the end of the road. The biotech is immediately winding down clinical and manufacturing operations and laying off almost all staff. Around 95% ...

JCR announced that the Company presented preclinical data from its novel adeno-associated virus (AAV) gene therapy research programs at ASGCT 2025.

Discover LumiSTAR, a Taiwan biotech leader combining iPSC technology and patented bioimaging (LumiRDT) to revolutionize drug discovery and cell therapy platforms.

CHICAGO — An autologous point-of-care cell therapy for adults with ischemic HF with reduced ejection fraction was safe and may be beneficial for select candidates, though a pivotal study did ...